染料木黄酮阻断DNA-PKcs/Akt2/Rac1通路抑制胶质母细胞瘤放疗后侵袭迁移
本研究以DNA-PKcs阳性与阴性的胶质母细胞瘤(GBM)细胞为对象,经X线照射后开展体外与NOD-SCID小鼠体内实验。结果显示放疗增强DNA-PKcs阳性GBM细胞的迁移侵袭并激活DNA-PKcs/Akt2/Rac1通路,染料木黄酮可特异性结合DNA-PKcs阻断该通路,从而抑制放疗诱导的侵袭迁移。
要点
- X线照射增强DNA-PKcs阳性而非阴性GBM细胞的迁移与侵袭。
- 染料木黄酮特异性结合DNA-PKcs并阻断DNA-PKcs/Akt2/Rac1通路。
- DNA-PKcs可作为预测GBM放疗后侵袭迁移的潜在生物标志物。
核心结论
- DNA-PKcs既是潜在治疗靶点,也是预测GBM细胞放疗后侵袭迁移的可靠生物标志物。
- 染料木黄酮可能成为治疗GBM的新型治疗策略。
研究设计与样本
- 选取DNA-PKcs阳性与阴性的GBM细胞系,经X线照射,开展体外与体内研究。
- 体外采用克隆形成实验、实时细胞电子传感系统、划痕愈合与transwell实验及western blotting。
- 采用pull-down、重组与结合实验评估染料木黄酮与DNA-PKcs的相互作用。
- 体内将细胞立体定向注射入NOD-SCID小鼠建立肿瘤,用HE与免疫组化评估侵袭潜能。
主要发现
- X线照射增强DNA-PKcs阳性GBM细胞的迁移与侵袭,对DNA-PKcs阴性细胞无此作用。
- 照射激活DNA-PKcs/Akt2/Rac1信号通路,加重GBM细胞侵袭潜能。
- 染料木黄酮可特异性结合DNA-PKcs并阻断该通路,体外与体内均抑制放疗诱导的侵袭迁移。
- 研究确定了染料木黄酮与DNA-PKcs结合的具体位点。
临床怎么用
- 对DNA-PKcs阳性GBM患者,放疗后需关注照射野邻近区域的侵袭迁移风险。
- 染料木黄酮联合放疗可能作为抑制GBM放疗后侵袭迁移的候选策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Radiotherapy is the most important therapeutic measure against glioblastoma multiforme (GBM), which is regarded as the most common and highly lethal type of brain cancer. Nevertheless, most relapses originate in the close vicinity of the irradiated target volume. Genistein is a natural product that can suppress the invasive potential of cancer cells. In this study, DNA-dependent protein kinase catalytic subunit (DNA-PKcs)-proficient and -deficient GBM cells were selected for in vitro and in vivo studies to investigate the inhibiting effects of genistein on radiation-induced invasion and migration and the corresponding mechanism. MATERIALS AND METHODS: GBM cell lines with or without genistein pre-treatment were irradiated with X-rays. Cell survival was determined using colony formation assay and the rate of cellular proliferation was analyzed with a real-time cell electronic sensing system. For in vitro study, invasion and migration abilities were evaluated via wound-healing and transwell assays, while protein expression was determined with western blotting. Genistein interaction with DNA-PKcs was estimated with pull-down, recombinant and binding assays. For in vivo study, cells were stereotactically injected into NOD-SCID mice to establish tumors. Hematoxylin and eosin and immunohistochemistry were used to assess the invasive potential of GBM. RESULTS: X-ray irradiation enhanced the migration and invasion of DNA-PKcs-positive but not DNA-PKcs-negative GBM cells. It also activated the DNA-PKcs/Akt2/Rac1 signaling pathway, which contributed to GBM malignant progression by aggravating GBM cell invasive potential. The study successfully demonstrated that genistein can specifically bind to DNA-PKcs and block the DNA-PKcs/Akt2/Rac1 pathway, thereby effectively inhibiting radiation-induced invasion and migration of GBM cells in vitro and in vivo. The present study emphasized that radiation-induced invasive potential is initiated by DNA-PKcs, which is a well-known double strand breaks (DSB) repair protein, and determined the exact site for genistein binding to DNA-PKcs. CONCLUSION: DNA-PKcs is not only a potential target for cancer therapy, but also a reliable biomarker for predicting radiation-induced invasion and migration of GBM cells. Thus, genistein might serve as a novel therapeutic strategy for treating GBM.
引用
- Liu X, Wang Q, Liu B, et al. Genistein inhibits radiation-induced invasion and migration of glioblastoma cells by blocking the DNA-PKcs/Akt2/Rac1 signaling pathway. Radiother Oncol. 2020. PMID: 33129924. doi:10.1016/j.radonc.2020.10.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。